Navigation Links
New genomics research project to eliminate Listeria from food supply
Date:6/27/2013

This news release is available in French.

OTTAWA -- Genome Canada, the Canadian Food Inspection Agency (CFIA), and Alberta Innovates Bio Solutions have partnered to support a $1.4 million project that will help protect consumers from Listeriosis, a serious foodborne illness caused by Listeria bacteria.

The project, led by Dr. Linda Chui of the University of Alberta, will sequence and map the genomes of many Listeria strains to identify those strains that are likely to be most harmful to human health as well as those most likely to survive in food processing facilities. This research will lead to faster and more cost-effective ways to screen food for the Listeria bacteria and bolster food safety for Canadians.

"The Harper Government is committed to improving Canada's already robust food safety system, as outlined in the Safe Food for Canadians Action Plan," said Agriculture Minister Gerry Ritz. "Through continued investments in science and innovation, we are creating opportunities to better identify and reduce risks for consumers, meaning safer food for Canadian families."

"We are pleased to see our investments in genomics research having tangible results," said the Honourable Gary Goodyear, Minister of State (Science and Technology). "This project shows how Canada's leadership in genomics-based research benefits Canadians by helping protect consumers from serious foodborne illness while developing a more competitive food sector."

Through this joint research effort, a database of Listeria genome sequences will be developed and genetic markers identified. These markers will be used to rapidly spot harmful Listeria strains in foods and food processing facilities.

"Genomics research such as this is equipping us with new, effective ways to combat threats to food safety. The impact this research will have on averting potential outbreaks and the consequences for Canadian families and industry is tremendous," said Pierre Meulien, President and CEO of Genome Canada.

"Ensuring the safety of food products is critical to public health and the competitiveness of our agri-food and agriculture industries," said Dr. Stan Blade, Chief Executive Officer of Alberta Innovates Bio Solutions. "New Listeria detection tests that produce results quickly will allow food producers and regulators to act swiftly and provides assurance of an even higher level of food safety for Canadians," he added.

Dr. Chui's 18-month research project is supported through an investment of $250,000 each from Genome Canada (via Genome Alberta) and the CFIA, and $100,000 from Alberta Innovates Bio Solutions. This investment is also being leveraged through co-funding from federal, provincial, academic and industry partners, including Maple Leaf Foods, increasing the total investment to $1.4 million.

"The strength of our project is in the world-class expertise of the research team and the support of many distinguished organizations from across Canada," said Dr. Chui. "The different researchers on the team bring leading-edge expertise in many areas including food sample preparation, assays development, state-of-the art capacity in bioinformatics and genomics, pathogen detection and outbreak response."


'/>"/>

Contact: Andrea Matyas
amatyas@genomecanada.ca
613-751-4460 x231
Genome Canada
Source:Eurekalert

Related biology news :

1. SDSCs big data expertise aiding genomics research
2. BGI, University of Helsinki and Wuhan University sign a MOU concerning cooperation on genomics
3. In search for a vaccine, IU biologist receives $2.3 million to explore chlamydia genomics
4. ACRG and BGI report findings from genomics research on recurrent hepatitis B virus integration
5. The genomics symposium to boost the further development of cancer research
6. Elsevier launches new open access journal: Applied and Translational Genomics
7. ShanghaiBio Corporation Partners with Ingenuity Systems to Address Challenges in Analysis and Interpretation of Genomics Data
8. 2 pioneering plant genomics efforts given a funding boost by National Science Foundation
9. Physiological Genomics journal announces a major restructuring
10. New genomics study shows ancestry could help solve disease riddles
11. Ontario Genomics Institute invests in validation of a novel protein interaction technology at U of T
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2016)... NEW YORK , May 16, 2016   ... authentication solutions, today announced the opening of an IoT ... to strengthen and expand the development of embedded ... provides an unprecedented level of convenience and security with ... to authenticate one,s identity aside from DNA. EyeLock,s platform ...
(Date:4/28/2016)... 28, 2016 First quarter 2016:   ... compared with the first quarter of 2015 The gross ... M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... is unchanged, SEK 7,000-8,500 M. The operating margin for ...
(Date:4/15/2016)... DUBLIN , April 15, 2016 ... of the,  "Global Gait Biometrics Market 2016-2020,"  report ... http://photos.prnewswire.com/prnh/20160330/349511LOGO ) , ,The global gait ... CAGR of 13.98% during the period 2016-2020. ... movement angles, which can be used to compute ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... PHILADELPHIA , June 27, 2016  Liquid ... today announced the funding of a Sponsored Research ... study circulating tumor cells (CTCs) from cancer patients.  ... changes in CTC levels correlate with clinical outcomes ... therapies. These data will then be employed to ...
(Date:6/24/2016)... ... , ... While the majority of commercial spectrophotometers and fluorometers use the z-dimension ... are higher end machines that use the more unconventional z-dimension of 20mm. Z-dimension ... bottom of the cuvette holder. , FireflySci has developed several Agilent flow cell ...
(Date:6/23/2016)... CAMBRIDGE, Mass. , June 23, 2016 /PRNewswire/ ... the development of novel compounds designed to target ... compound, napabucasin, has been granted Orphan Drug Designation ... in the treatment of gastric cancer, including gastroesophageal ... cancer stemness inhibitor designed to inhibit cancer stemness ...
(Date:6/23/2016)... ... 23, 2016 , ... Charm Sciences, Inc. is pleased to ... AOAC Research Institute approval 061601. , “This is another AOAC-RI approval of the ... Vice President of Regulatory and Industrial Affairs. “The Peel Plate methods perform comparably ...
Breaking Biology Technology: